Okiemute H. Vukadinovic, NP

Okiemute Vukadinovic practices at Washington Center in San Leandro, California.

Okiemute Vukadinovic's NPI, 1316677495, was assigned on June 13, 2022. Okiemute Vukadinovic holds Texas license 1008906.

Okiemute Vukadinovic's primary practice is Washington Center, at 14766 Washington Avenue, San Leandro, CA 94578 in Alameda County. The practice phone is (510) 352-2211.

Okiemute Vukadinovic's primary practice is Washington Center in San Leandro, California. The medical group on file is CareConnectMD. Dmand AI also links Okiemute Vukadinovic to 6 more medical groups, 4 skilled nursing facilities and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Okiemute Vukadinovic practices, 6 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Okiemute Vukadinovic's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Dmand AI has Okiemute Vukadinovic's licenses on file in 2 states: Texas and California.

Dmand AI lists anxiety, chronic diabetes, chronic kidney disease, enlarged prostate, epilepsy, high cholesterol, mobility impairment and parkinson's disease among the conditions Okiemute Vukadinovic treats.

CMS data shows 515 Medicare services from Okiemute Vukadinovic across 5 procedure codes in 2024, for 168 Medicare patients. Medicare paid $30,630 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 168 Medicare patients who saw Okiemute Vukadinovic in 2024. The largest group is 85 and over, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 61% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Okiemute Vukadinovic's median patient age at 77, with 41% women.

In 2024, Okiemute Vukadinovic wrote 70 Medicare Part D claims for 28 patients. 86% of them were for generic drugs.

Okiemute Vukadinovic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Okiemute Vukadinovic as offering telehealth.

CMS Open Payments shows 4 general payments to Okiemute Vukadinovic from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Revance Therapeutics, Inc. paid the most, $159.